Guillain-Barré syndrome (GBS) is a rare but serious neurological disorder in which the body's immune system mistakenly attacks the peripheral nerves. Early symptoms typically include tingling sensations or “pins and needles” in the extremities—most often in the fingers, toes, ankles, or wrists. This is usually followed by progressive muscle weakness that begins in the legs and may spread upward to the arms and upper body.
Other key symptoms include difficulty walking or climbing stairs due to unsteadiness, facial muscle impairment affecting speech, chewing, or swallowing, and vision disturbances such as double vision or trouble moving the eyes. Patients may also experience intense, cramp-like pain—particularly at night—along with bladder or bowel dysfunction, irregular heart rate, and fluctuating blood pressure. In severe cases, GBS can weaken respiratory muscles, leading to life-threatening breathing difficulties that may require mechanical ventilation.
Symptoms generally develop rapidly, often worsening over a period of two to three weeks. Because GBS can progress quickly and compromise critical bodily functions, prompt diagnosis and treatment are essential. The exact cause of GBS remains unclear, but it is often preceded by infections, particularly Campylobacter jejuni (a gastrointestinal bacterium), as well as respiratory viruses like influenza or, more recently, SARS-CoV-2 (COVID-19).
Treatment typically includes intravenous immunoglobulin (IVIG) or plasmapheresis, which help reduce immune system attack on the nerves. While most individuals recover fully or significantly, recovery can take weeks to several years, and some may experience lingering weakness or fatigue. Recent studies suggest that early rehabilitation can improve long-term outcomes.
Given its potentially rapid progression and impact on vital functions, Guillain-Barré syndrome is considered a medical emergency. Increased awareness and timely intervention are crucial for improving recovery and minimizing complications.
Guillain-Barré Syndrome: Symptoms, Progression, and Recovery
Clostridium perfringens: Understanding and Managing Gastrointestinal
Infections
-
Gastrointestinal infections caused by Clostridium perfringens, termed
enterotoxemias, exhibit a significant impact across various mammalian
species, underl...